List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 24 studies with search of: "Finasteride"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions
Condition: Healthy
Interventions: Drug: Finasteride 5 mg Tablet, single dose;   Drug: Proscar® 5 mg Tablet, single dose
2 Completed A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: Finasteride 5 mg Tablet, single dose;   Drug: Proscar® 5 mg Tablet, single dose
3 Not yet recruiting Oral T-7 Oral Androgens in Man-7
Condition: Healthy Males
Interventions: Drug: Acyline;   Drug: Testosterone Undecanoate;   Drug: Finasteride 0.5 mg;   Drug: Finasteride 1 mg
4 Recruiting A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy
Condition: Enlarged Prostate
Interventions: Drug: Finasteride;   Drug: Placebo
5 Completed Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg
Condition: Healthy
Interventions: Drug: Finasteride Tablets 5 mg;   Drug: Proscar® Tablets 5 mg
6 Completed Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
Condition: Healthy
Interventions: Drug: Finasteride Tablets 5 mg;   Drug: Proscar Tablets 5 mg
7 Active, not recruiting On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Finasteride;   Drug: Placebo
8 Recruiting The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
Conditions: Hematuria;   Hematospermia
Intervention: Drug: Finasteride
9 Completed Finasteride 5 mg Tablets, Fasting
Condition: Healthy
Interventions: Drug: Finasteride 5 mg tablets;   Drug: PROSCAR®
10 Completed Finasteride 5 mg Tablets, Non-Fasting
Condition: Healthy
Interventions: Drug: Finasteride 5 mg tablets;   Drug: PROSCAR® 5mg tablets
11 Recruiting Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Condition: Retinal Disease
Intervention: Drug: Finasteride
12 Active, not recruiting Kinetics of the Finasteride Prostate Induced Apoptosis
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: finasteride
13 Suspended Finasteride in Treating Patients Undergoing Surgery for Stage II Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: finasteride;   Other: placebo
14 Recruiting 5-Alpha Reductase and Anabolic Effects of Testosterone
Conditions: Male Hypogonadism;   Muscle Atrophy;   Prostate Enlargement;   Sarcopenia
Interventions: Drug: Testosterone Enanthate;   Behavioral: Collection of 3-day food logs with counseling of subjects;   Drug: Finasteride;   Behavioral: Collection of 3-day food logs with counseling of subjects;   Drug: Testosterone Enanthate;   Drug: Finasteride;   Behavioral: Collection of 3-day food logs with counseling of subjects
15 Completed Topical Finasteride in the Treatment of Idiopathic Hirsutism
Condition: Idiopathic Hirsutism
Intervention: Drug: topical finasteride
16 Recruiting Selenomethionine and Finasteride Before Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: selenomethionine;   Drug: finasteride;   Other: placebo
17 Completed Effects of Finasteride on Serum Prostate-Specific Antigen
Condition: Androgenetic Alopecia
Interventions: Drug: MK0906, finasteride / Duration of Treatment : 48 Weeks;   Drug: Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks
18 Completed Medical Therapy of Prostatic Symptoms (MTOPS)
Conditions: Prostatic Hyperplasia;   Prostatic Hypertrophy, Benign
Interventions: Drug: Doxazosin;   Drug: Finasteride
19 Completed Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
Conditions: Benign Prostatic Hyperplasia (BPH);   Enlarged Prostate
Interventions: Drug: 2.5 mg NX-1207;   Drug: 0.125 mg NX-1207;   Drug: finasteride
20 Terminated Minimally Invasive Surgical Therapy for BPH
Condition: Benign Prostatic Hyperplasia
Interventions: Device: Transurethral Microwave Thermotherapy (TUMT);   Device: Transurethral Needle Ablation (TUNA) Therapy;   Drug: Finasteride and Alfuzosin

Previous Page Studies Shown (1-20) Next Page (21-24)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services